arrow
R

Rimke Oostvogels

department of hematology
H指数:13
被引数:798

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world efficacy and safety of immunochemotherapy in cold agglutinin-mediated autoimmune haemolytic anaemia

冷凝集素介导的自身免疫性溶血性贫血中免疫化疗的疗效与安全性

2025-10-220
OAAI
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies
2024-12-010
PRE
Bispecific Antibodies for Multiple Myeloma in the Real World: Lessons Learnt from a Nation-Wide Dutch Observational Registry

双特异性抗体在多发性骨髓瘤真实世界中的应用:来自荷兰全国性观察性登记研究的经验教训

BLOOD
IF23.1
2024-11-050
PRE
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands
2023-10-051
OAAI
SARS-CoV-2 Infection in Patients With Waldenstrom's Macroglobulinemia: A Multicenter International Cohort Study
2023-06-011
OAAI
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis
2022-11-013
OAAI
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
2016-05-01109
OAAI
Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2-Restricted T Cell Epitopes

改变的肽配体重新审视: 通过化学修饰的HLA-A2-Restricted T细胞表位进行疫苗设计

2014-11-1560
OAAI